{"id":230508,"date":"2026-09-04T09:54:21","date_gmt":"2026-09-04T04:24:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=230508"},"modified":"2026-09-04T09:54:21","modified_gmt":"2026-09-04T04:24:21","slug":"why-caplin-point-laboratories-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-share-price-fall-today-2026\/","title":{"rendered":"Caplin Point Laboratories (CAPLIPOINT) Share Price Falls 2.77% Today"},"content":{"rendered":"
Caplin Point Laboratories (CAPLIPOINT)<\/a>share price fell to Rs 2,764 today, down 2.77% from the previous close. Market cap was Rs 20,634.9 crore.<\/em><\/div>\n

Caplin Point Laboratories Share Price fell to Rs 2,764 on 04 September 2026, down 2.77% for the day, taking the company\u2019s market capitalisation to Rs 20,634.9 crore. The Large Cap pharmaceutical stock opened at Rs 2,867.1 and moved lower through the session, with today\u2019s decline drawing attention because the stock slipped from a previous close of Rs 2,842.8 to its intraday low of Rs 2,764.<\/p>\n

For investors tracking Caplin Point Laboratories Share Price Today and broader stock market moves, the supplied data confirms the price event but does not establish a company-specific catalyst behind the fall. What is clear is that the stock is trending because of a notable single-day decline, while the company\u2019s valuation and profitability profile remain important to the discussion. At the current price, the stock trades at a P\/E ratio of 51.48 and a P\/B ratio of 9.95, with ROE at 21.36% and ROCE at 27.07%. On Univest, this makes the stock relevant not only for today\u2019s price action but also for its premium positioning within the Healthcare and Pharmaceuticals & Drugs segment.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n